Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ProPhase Labs (PRPH) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for ProPhase Labs (PRPH) over the last 15 years, with Q3 2025 value amounting to $41.5 million.

  • ProPhase Labs' Shares Outstanding (Weighted Average) rose 11773.15% to $41.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.5 million, marking a year-over-year increase of 11773.15%. This contributed to the annual value of $20.5 million for FY2024, which is 1892.25% up from last year.
  • Latest data reveals that ProPhase Labs reported Shares Outstanding (Weighted Average) of $41.5 million as of Q3 2025, which was up 11773.15% from $41.5 million recorded in Q2 2025.
  • ProPhase Labs' Shares Outstanding (Weighted Average)'s 5-year high stood at $41.5 million during Q2 2025, with a 5-year trough of $14563.0 in Q1 2021.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $16.8 million (2023), whereas its average is $16.3 million.
  • Per our database at Business Quant, ProPhase Labs' Shares Outstanding (Weighted Average) plummeted by 9987.43% in 2021 and then skyrocketed by 10804929.61% in 2023.
  • Over the past 5 years, ProPhase Labs' Shares Outstanding (Weighted Average) (Quarter) stood at $15.2 million in 2021, then rose by 4.44% to $15.8 million in 2022, then rose by 8.6% to $17.2 million in 2023, then rose by 18.92% to $20.5 million in 2024, then surged by 103.01% to $41.5 million in 2025.
  • Its last three reported values are $41.5 million in Q3 2025, $41.5 million for Q2 2025, and $35.2 million during Q1 2025.